Kenyan Health Patient Information Leaflet
Therapeutic agent (verify pharmacological class)
Promotion of gingival health and prevention dental plaque, reducing gingivitis and halitosis Clinical selection for Cetylpyridinium chloride mouthwash should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Therapeutic agent (verify pharmacological class). Confirm site-specific dose, duration and monitoring before prescribing.
Swish mouthwash around the mouth for 30 seconds BD
Adverse reactions vary by agent. Counsel on common predictable effects and serious warning symptoms (allergy, severe rash, jaundice, unusual bleeding, severe GI symptoms, neurological changes). Report suspected ADRs via national pharmacovigilance channels.
Store as labelled. Keep out of reach of children.